CMPX CMPX R2K
$2.38
+13.33% 1Y
Market & Price
Market Cap
-
Current Price
$2.38
High / Low (52W)
$6.69 / $1.67
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-35.42%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.10
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$219.59M
Current Assets
$209.82M
Working Capital
$195.85M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-
Profit 5Y
-23.17%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -23.2% CAGR over 5 years.
- Trading 64.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | - | 850.00K | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.97M | 21.07M | 15.82M | 17.99M | 20.30M |
| Operating Income | -7.89K | -7.79K | -9.27K | - | -8.67M | -8.38M | -10.24K | -5.83M | -5.07M | -8.96M | -7.34M | -55.69M | -5.85M | -7.18M | -8.99M | -12.60M | -9.71M | -13.34M | -11.93M | -12.77M | -15.04M | - | - | -17.97M | -21.07M | -15.82M | -17.99M | -20.30M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -17.60M | -20.70M | -15.45M | -17.62M | -19.93M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -16.63M | -19.88M | -14.26M | -15.72M | -18.32M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - |
| Net Income | -8.47K | -8.56K | -10.14K | -10.77M | -8.81M | -8.55M | -11.68K | -6.40M | -5.56M | -9.15M | -7.42M | -55.80M | -5.97M | -7.16M | -8.49M | -11.97M | -7.84M | -11.28M | -9.96M | -10.79M | -13.08M | - | - | -16.63M | -19.88M | -14.26M | -15.72M | -18.32M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.12 | -0.14 | -0.08 | -0.09 | -0.10 |
| R&D Expense | - | - | - | - | 5.39M | 5.98M | - | 3.57M | 2.98M | 3.67M | 4.70M | - | - | - | - | - | - | - | - | 9.52M | 11.17M | 8.61M | - | 13.05M | 16.41M | 12.83M | - | 13.39M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2019 | Dec 2019 | Mar 2020 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 0 | 0 | 850.00K | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | 41.66M | 50.36M | 57.48M | 72.84M |
| Operating Income | -32.76K | -34.05M | -32.10K | -27.81M | - | -41.66M | -50.36M | -56.62M | -72.84M |
| EBITDA | - | - | - | - | - | -39.75M | -48.47M | -54.87M | -71.37M |
| Interest Expense | - | - | - | - | 370.00K | 0 | - | - | - |
| Pretax Income | - | - | - | - | - | -39.23M | -42.49M | -49.38M | -66.49M |
| Tax Provision | - | - | - | - | 0 | 0 | 0 | 0 | - |
| Net Income | -36.04K | -34.74M | -37.48K | -29.50M | - | -39.23M | -42.49M | -49.38M | -66.49M |
| Diluted EPS | - | - | - | - | -1.31 | -0.37 | -0.33 | -0.36 | - |
| R&D Expense | - | 22.45M | - | 14.90M | - | - | 38.12M | 42.34M | 55.97M |
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -23.17% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +13.33% |
| 6 Months: | -52.50% |
| 3 Months: | -57.88% |
| 1 Month: | +42.51% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2018 | Dec 2018 | Mar 2019 | Dec 2019 | Mar 2020 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 25 | - | 4.87K | 30.38M | 3.75K | 51.91M | - | 199.65M | 156.88M | 140.40M | 219.59M |
| Current Assets | - | - | - | - | - | - | - | 194.79M | 153.88M | 132.75M | 209.82M |
| Cash & Equivalents | - | - | 4.87K | 25.30M | 3.75K | 47.08M | - | 34.95M | 24.23M | 43.48M | 30.64M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | 34.58K | - | 75.45K | 19.11M | 111.82K | 11.97M | - | 18.01M | 8.34M | 15.17M | 22.80M |
| Current Liabilities | 34.58K | - | 75.45K | 9.82M | 111.82K | 10.10M | - | 16.17M | 7.80M | 8.87M | 13.97M |
| Long Term Debt | - | - | - | 9.29M | - | 1.87M | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | 2.94M | 1.73M | 6.63M | 9.83M |
| Total Equity | -34.55K | -84.77M | -70.59K | 11.27M | -108.07K | 39.95M | - | 181.64M | 148.54M | 125.23M | 196.79M |
| Shares Outstanding | - | - | - | - | - | - | - | 126.30M | 127.67M | 137.82M | 178.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2019 | Dec 2019 | Mar 2020 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.76K | -31.74M | -32.11K | -26.80M | - | -34.12M | -40.62M | -44.85M | -49.14M |
| Investing Cash Flow | - | -466.00K | - | 38.00K | - | -151.20M | 26.96M | 46.77M | -93.31M |
| Financing Cash Flow | 37.62K | - | 30.98K | 48.54M | - | 75.76M | 2.94M | 17.34M | 129.61M |
| Capital Expenditure | - | -466.00K | - | -106.00K | - | -212.00K | -30.00K | -44.00K | -25.00K |
| Free Cash Flow | - | -32.21M | - | -26.91M | - | -34.34M | -40.65M | -44.90M | -49.17M |
| Net Change in Cash | - | - | - | - | - | -109.57M | -10.72M | 19.25M | -12.84M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2019 | Dec 2019 | Mar 2020 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | -6,661.8% | - |
| Net Margin % | - | - | - | - | - | - | - | -5,808.8% | - |
| ROE % | 51.1% | -308.4% | 34.7% | -73.9% | - | -21.6% | -28.6% | -39.4% | -33.8% |
| ROCE % | 46.4% | -165.6% | 29.7% | -66.5% | - | -22.7% | -33.8% | -43.1% | -35.4% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CMPX
No recent headlines available.